← Leaderboards
Chad A Dickey
Mayo Clinic Jacksonville
$4,755,254
Attributed
$5,179,105
Total exposure
9
Grants
9
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $1.2M · FY2005–16$2M$1.5M$1M$500K$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
Funding mix
By agency
NIH$5,179,105 · 7
VA$0 · 2
By mechanism
R01$3,810,167 · 3
R00$888,669 · 1
R41$286,284 · 1
F32$105,751 · 1
K99$88,234 · 1
I01$0 · 2
Top collaborators
- Brian S J Blagg2 shared
Most similar at Mayo Clinic Jacksonville
Same institution · by research overlap
- James Shorter$11,511,778
Others in their field
Top investigators on “Proteins”
- David Heimbrook · Leidos Biomedical Research, Inc.$354,061,551
- Randall J Bateman · Washington University$187,292,085
- Paul S. Aisen · Cognition Therapeutics, Inc.$175,382,342
- Reisa A. Sperling · Banner Health$145,046,481
- Barton F Haynes · Duke University$136,029,850
- Joseph L Goldstein · University Of Texas Sw Med Ctr/Dallas$102,433,280
Research focus
ProteinsAlzheimer&AposBrainTau ProteinsS DiseaseTauopathiesTherapeutic TargetMolecular ChaperonesCellsLinkTransgenic MiceTau AggregationBiologyGenesComplexNeurodegenerative DisordersLeadMouse ModelNeuronsMediatingTau MutationPreventSignal TransductionPathology
Grant awards (28)
The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function$427,241
R01 · FY2016 · NS · contact PI
The hsp90 Cochaperone FKBP51 Regulates tau Structure and Function$27,907
R01 · FY2016 · NS · contact PI
UPR as a Neuronal Death Mediator in Alzheimer's Disease$0
I01 · FY2016 · VA · contact PI
Hsp70/DnaJ interface as a drug target for Alzheimer's disease and TBI$0
I01 · FY2016 · VA · contact PI
Grp94-selective inhibitors to treat heredity glaucoma$412,324
R01 · FY2015 · EY · contact PI
Modeling stress-related psychopathology through FKBP5 manipulation$376,350
R01 · FY2015 · MH · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$373,794
R01 · FY2015 · NS · contact PI
UPR as a Neuronal Death Mediator in Alzheimer's Disease$0
I01 · FY2015 · VA · contact PI
Hsp70/DnaJ interface as a drug target for Alzheimer's disease and TBI$0
I01 · FY2015 · VA · contact PI
Grp94-selective inhibitors to treat heredity glaucoma$435,379
R01 · FY2014 · EY · contact PI
Modeling stress-related psychopathology through FKBP5 manipulation$388,725
R01 · FY2014 · MH · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$370,056
R01 · FY2014 · NS · contact PI
Hsp70/DnaJ interface as a drug target for Alzheimer's disease and TBI$0
I01 · FY2014 · VA · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$306,736
R01 · FY2013 · NS · contact PI
A Diarylheptanoid Scaffold to Treat Taopathies$286,284
R41 · FY2013 · AG · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$55,933
R01 · FY2013 · NS · contact PI
Hsp70/DnaJ interface as a drug target for Alzheimer's disease and TBI$0
I01 · FY2013 · VA · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$317,861
R01 · FY2012 · NS · contact PI
The Hsp90 cochaperone FKBP51 regulates tau structure and function$317,861
R01 · FY2011 · NS · contact PI
Chaperone-mediated signaling in Alzheimer's disease$293,716
R00 · FY2010 · AG · contact PI
Chaperone-mediated signaling in Alzheimer's disease$322,114
R00 · FY2009 · AG · contact PI
Chaperone-mediated signaling in Alzheimer's disease$23,843
R00 · FY2009 · AG · contact PI
Chaperone-mediated signaling in Alzheimer's disease$248,996
R00 · FY2008 · AG · contact PI
Chaperone-mediated signaling in Alzheimer's disease$88,234
K99 · FY2007 · AG · contact PI
Therapeutic Intervention for Tauopathies$12,979
F32 · FY2007 · AG · contact PI
Therapeutic Intervention for Tauopathies$45,400
F32 · FY2006 · AG · contact PI
Therapeutic Intervention for Tauopathies$3,396
F32 · FY2006 · AG · contact PI
Therapeutic Intervention for Tauopathies$43,976
F32 · FY2005 · AG